Here’s a concise, up-to-date overview of lisinopril, plus how to get the very latest 2026 details.
What lisinopril is
- Drug class: ACE inhibitor (angiotensin‑converting enzyme inhibitor).
- Mechanism: Lowers blood pressure and reduces strain on the heart by blocking the formation of angiotensin II, leading to vasodilation and reduced aldosterone.
- Formulations: Oral tablets (commonly 2.5, 5, 10, 20, 30, 40 mg). Brand names include Zestril and Prinivil; many generics are available. Often combined with other agents (e.g., lisinopril/HCTZ).
Approved uses (typical in the U.S.)
- Hypertension (high blood pressure).
- Heart failure, to improve symptoms and survival.
- Post-myocardial infarction (MI) to improve survival in certain patients.
- In some settings, used for diabetic nephropathy and other kidney protections due to kidney-protective effects, but labeling specifics vary.
Typical dosing guidance (general, for reference; always follow the product label and your clinician)
- Hypertension:
- Starting: often 5 mg once daily.
- Titration: may increase every 1–2 weeks based on response and tolerance.
- Usual target range: up to 20–40 mg per day (some patients use 40 mg once daily or split dosing).
- Heart failure:
- Starting: commonly 2.5 mg once daily.
- Titration: gradual increases over weeks to a typical target of 20–40 mg daily (in divided doses or once daily, as tolerated).
- Post-MI:
- Starting: often 5 mg within 24 hours if hemodynamically stable.
- Then 10 mg after 24 hours, with further titration up to 20–40 mg daily, as tolerated.
Key safety and monitoring
- Common adverse effects: dizziness, lightheadedness (especially with start or uptitration), cough, hyperkalemia (high potassium), rare angioedema.
- Serious risks: angioedema (more likely in Black patients; can occur at any time), kidney function impact, hypotension.
- Contraindications: pregnancy (risk to fetus; ACE inhibitors are teratogenic in later pregnancy), history of ACE-inhibitor–associated angioedema, bilateral renal artery stenosis.
- Interactions to watch:
- NSAIDs can reduce lisinopril’s antihypertensive effect and may worsen kidney function.
- Potassium-sparing drugs or supplements and other drugs that increase potassium can raise the risk of hyperkalemia.
- Other blood pressure medicines and aliskiren (in certain patients) can interact.
- Monitoring plan:
- Blood pressure to assess effectiveness.
- Kidney function (creatinine, eGFR) and electrolytes (especially potassium) after starting or changing dose.
- Watch for signs of angioedema (swelling of face/lips/tongue; seek urgent care if this occurs).
Pregnancy and lactation
- ACE inhibitors like lisinopril are contraindicated in pregnancy due to risk to the fetus (especially in the second and third trimesters). If pregnancy is planned or suspected, discuss alternatives with your clinician.
- Not routinely recommended during breastfeeding; consult your clinician.
Special considerations
- Lisinopril is primarily excreted unchanged by the kidneys; dose adjustments are often needed in kidney impairment.
- Hepatic impairment generally does not require dose adjustment, but renal function and electrolytes remain the primary monitoring focus.
- Pediatric use is possible for certain hypertension cases, but dosing and safety are different from adults.
Where to find the latest 2026 information
- FDA labeling: The most authoritative source for approved indications, dosing, contraindications, and safety notes.
- DailyMed (FDA’s label repository): Quick access to the current lisinopril label.
- Pharmacology and clinical guidelines: ACC/AHA hypertension guidelines (and other specialty guidelines) for how lisinopril fits into broader treatment plans; note that guidelines evolve.
- Drug reference sites (e.g., Drugs.com, Lexicomp, UpToDate, Medscape) for summaries and patient handouts.
What I can do next
- If you tell me your role (patient, caregiver, clinician) and what you want updated for 2026 (label changes, dosing guidance, safety updates, or a patient-friendly summary), I can tailor:
- A concise patient-friendly info sheet.
- A quick dosing reference by condition (hypertension, heart failure, post-MI).
- A checklist for what to monitor and when to contact a clinician.
- A short guide to finding the official 2026 label and guidelines.
Would you like a quick, patient-friendly summary of lisinopril for 2026, or a clinician-focused dosing and monitoring cheat sheet? If you have a specific context (hypertension vs heart failure vs post-MI), I can tailor it.